查看完整行情页>>

|

货币单位:美元(USD)

AcelRx Pharmaceuticals, Inc. (acrx)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Howard B. Rosen Howard B. Rosen is a businessperson who has been at the head of 5 different companies is Member of National Academy of Engineering and on the board of 7 other companies. In his past career he occupied the position of Principal at Integral, Inc., Consultant at McKinsey & Co., Inc., Vice President-Commercial Strategy at Gilead Sciences, Inc., Chairman for Alcobra Ltd., President & Chief Executive Officer at Pearl Therapeutics, Inc., President at ALZA Corp. and Director-Corporate Development at GenPharm International, Inc. Howard B. Rosen received an undergraduate degree from Stanford University, a graduate degree from Massachusetts Institute of Technology and an MBA from Stanford Graduate School of Business.
Mark Allen Wan Founder of 5 different companies, notably: Odyssey HealthCare, Inc., Epocrates LLC and Perclose, Inc. Mark Allen Wan is an entrepreneur and currently is Managing Director at Causeway Management LLC (which he founded in 2013) and Managing Director at Three Arch Partners (which he founded in 2009), Member of Three Arch Management LP (a subsidiary of Three Arch Partners). He is also Member of Three Arch Management LP and on the board of 14 other companies. Mr. Wan previously occupied the position of Non-Executive Chairman at QT Vascular Ltd., General Partner for Brentwood Associates, Managing Member at Three Arch Management IV LLC, Director at Odyssey HealthCare, Inc. and Independent Director at Epocrates LLC. He received an undergraduate degree from Yale University and an MBA from Stanford Graduate School of Business.
Adrian Adams Adrian Adams is a businessperson who has been at the helm of 13 different companies and presently is Chairman for AcelRx Pharmaceuticals, Inc., Chairman for Akebia Therapeutics, Inc. and Chairman & Chief Executive Officer of Impel NeuroPharma, Inc. He previously held the position of Chairman & Chief Executive Officer for Neurologix, Inc., Chief Executive Officer for Aralez Pharmaceuticals Plc, Chief Executive Officer & Director at Aralez Pharmaceuticals, Inc. and Chief Executive Officer & Director at POZEN, Inc. (a subsidiary of Aralez Pharmaceuticals, Inc.), Director-Sales & Marketing of ICI Pharmaceuticals, President, Chief Executive Officer & Director at Auxilium Pharmaceuticals LLC, President & Chief Executive Officer for Sunovion Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Inspire Pharmaceuticals, Inc., President & Chief Executive Officer at KOS Pharmaceuticals, Inc., President & Chief Executive Officer of Smithkline Beecham Plc and President & Chief Executive Officer of Novartis Pharmaceuticals UK Ltd. Adrian Adams received an undergraduate degree from The University of Manchester and an undergraduate degree from the University of Salford.
Stephen J. Hoffman Founder of Somatogen, Inc., Stephen J. Hoffman is a businessperson who has been the head of 6 different companies and currently is Managing Director at Skyline Management LLC. He is also on the board of 5 other companies. In his past career he was Chairman for Bicycle Therapeutics Plc, Chairman of Anchiano Therapeutics Ltd., Chief Executive Officer & Director at Aerpio Pharmaceuticals, Inc. and Chief Executive Officer & Director at Aerpio Therapeutics, Inc. (a subsidiary of Aerpio Pharmaceuticals, Inc.), Vice President-Science & Technology at Baxter International, Inc. and Vice President-Science & Technology at Somatogen, Inc. (a subsidiary of Baxter International, Inc.), General Partner at TVM Capital GmbH and General Partner of TVM Capital Corp. (a subsidiary of TVM Capital GmbH) and Chairman of Allos Therapeutics, Inc. Dr. Hoffman received a doctorate from Northwestern University and a doctorate from The University of Colorado School of Medicine.
Mark G. Edwards Founder of BioScience Advisors, Inc. and Recombinant Capital, Inc., Mark G. Edwards presently holds the position of Managing Director at BioScience Advisors, Inc. Mr. Edwards is also on the board of The Scripps Research Institute, AcelRx Pharmaceuticals, Inc., California Institute for Biomedical Research and Prolynx LLC. In the past Mr. Edwards held the position of Managing Director at Recombinant Capital, Inc., Managing Director & Principal at Deloitte Recap LLC and Manager-Business Development at Chiron Corp. He received an MBA and an undergraduate degree from Stanford University.
Vincent J. Angotti Vincent J. Angotti is Chief Executive Officer & Director at AcelRx Pharmaceuticals, Inc. In his past career Mr. Angotti was Chief Executive Officer of XenoPort, Inc., Executive Director-Field Operations at Novartis Pharmaceuticals Corp. and Senior Vice President-Sales & Marketing of Reliant Pharmaceuticals LLC. Mr. Angotti received an MBA from Columbia University and an undergraduate degree from Cornell University.
Badri N. Dasu Badri N. Dasu occupies the position of Chief Engineering Officer at AcelRx Pharmaceuticals, Inc. Mr. Dasu is also Member of American Association of Medical Instrumentation and Member of American Institute of Chemical Engineers. In the past Mr. Dasu held the position of Vice President-Medical Device Engineering at Anesiva, Inc. and Vice President-Manufacturing & Device Development at AlgoRx Pharmaceuticals, Inc. (a subsidiary of Anesiva, Inc.), Director-Process Development at Metrika, Inc., Vice President-Manufacturing & Process Development at Powderject Pharmaceuticals, Inc. and Director-Process Development at Cygnus, Inc. Mr. Dasu received an undergraduate degree from Mangalore University and a graduate degree from The University of Tulsa.
Richard F. Afable Richard F. Afable is a businessperson who has been at the helm of 6 different companies. He is on the board of Chapman University, AcelRx Pharmaceuticals, Inc., Providence Little Co. of Mary Medical Institute and OnSite Waste Technologies, Inc. He previously held the position of Chairman at California Hospital Association, Chief Executive Officer at Covenant Health Network, President & Chief Executive Officer of St. Joseph Hoag Health, President & Chief Executive Officer for Hoag Hospital Foundation, Chief Medical Officer for Catholic Health East, President & Chief Executive Officer at Hoag Memorial Hospital Presbyterian, Inc., Trustee at Providence St. Joseph Health, Professor at Wake Forest University and Professor at Northwestern University. Dr. Afable received a doctorate and an undergraduate degree from Loyola University of Chicago and a graduate degree from the University of Illinois.
Pamela Pierce Palmer Founder of Omeros Corp. and AcelRx Pharmaceuticals, Inc., Pamela Pierce Palmer currently occupies the position of Director & Chief Medical Officer at AcelRx Pharmaceuticals, Inc. She is also Professor at The University of California, San Francisco. Dr. Palmer previously was Director-Advanced Research & Education at UCSF Pain Management Center. She received a doctorate from Stanford University, a doctorate from Stanford University School of Medicine and an undergraduate degree from the University of Arizona.
Mark A. Evashenk Presently, Mark A. Evashenk is Vice President-Clinical Operations at AcelRx Pharmaceuticals, Inc. Mr. Evashenk previously was Director-Clinical Operations at ALZA Corp. Mr. Evashenk received an undergraduate degree from the University of California, Davis.
Raffi Asadorian Raffi Asadorian is Chief Financial & Accounting Officer for AcelRx Pharmaceuticals, Inc. He previously was Chief Financial Officer at Amyris, Inc., Chief Financial Officer at Unilabs SA, Chief Financial Officer & Senior Vice President for PLIVA dd and Partner-Transaction Services at PricewaterhouseCoopers LLP. Raffi Asadorian received an undergraduate degree from Xavier University and an MBA from Manchester Metropolitan University of.